GlassScriptPhysician profile
Tori Minick
NPI 1679322317
$471.81
in general payments reported to CMS, 2019-2025
14 companies · $472 in 2025
The $472 reported for 2025 was more than what 85% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $69.56 | 2025 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $67.36 | 2025 | Fanapt |
| Astellas Pharma US INC | $60.50 | 2025 | Veozah |
| Organon LLC | $53.24 | 2025 | Nexplanon |
| Janssen Pharmaceuticals, INC | $47.28 | 2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $31.57 | 2025 | Uzedy |
| Millicent US INC | $23.18 | 2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $20.30 | 2025 | |
| Inspire Medical Systems, INC. | $20.12 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $20.06 | 2025 | Aptima |
| Xeris Pharmaceuticals, INC. | $17.29 | 2025 | Gvoke Hypopen |
| Exeltis, USA INC. | $14.86 | 2025 | Slynd |
| Abbott Laboratories | $13.72 | 2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $12.77 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tori Minick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.